Tag: double-blind placebo-controlled food challenge (DBPCFC)
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler...
81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
Intrommune’s Peanut Allergy Toothpaste Therapy Reaches Phase 1 Clinical Trial Milestone
The process known as Oral Mucosal Immunotherapy does not involve ingesting the allergen.
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut...
According to research presented at this year's #ACAAI22 meeting.
Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment
Company is developing a patient-friendly treatment platform for peanut and other food allergies.
Viaskin Peanut Completes Phase III Part A Study of Toddlers With...
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.
